Clinical trial · Observational
Collecting and Storing Biological Samples From Young Patients With Hodgkin?s Lymphoma
Hodgkin Disease (HD) Banking Study
NCT00900250CI-TRIAL-00038040completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This laboratory study is collecting and storing samples of tissue and blood from young patients with Hodgkin's lymphoma. Collecting and storing samples of tumor tissue and blood from patients with cancer to study in the laboratory may help the study of cancer in the future.
Conditions
Conditions (5)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Ann Arbor Stage I Childhood Hodgkin Lymphoma | — | UNRESOLVED | — |
| Ann Arbor Stage II Childhood Hodgkin Lymphoma | — | UNRESOLVED | — |
| Ann Arbor Stage III Childhood Hodgkin Lymphoma | — | UNRESOLVED | — |
| Ann Arbor Stage IV Childhood Hodgkin Lymphoma | — | UNRESOLVED | — |
| Refractory Childhood Hodgkin Lymphoma | Childhood Hodgkin Lymphoma | CURATED_BROADER | 0.78 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Cytology Specimen Collection Procedure | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Ancillary-correlative (specimen collection and baking)
- description
- Patients enrolled on HL therapeutic clinical trials undergo collection of tumor tissue samples at baseline and at relapse or disease progression. Serum and anticoagulated peripheral blood samples are collected at baseline, at week 1, on day 1 of course 2, after completion of chemotherapy, after completion of radiotherapy, at 1 year after diagnosis, and at relapse or disease progression. Patients with relapsed or progressive disease who plan to enroll on HL relapse/retrieval clinical trials undergo collection of tumor tissue, serum, and anticoagulated peripheral blood samples at relapse or disease progression. Patients enrolled more than 1 year after completion of treatment undergo collection of tumor specimens, serum, and anticoagulated peripheral blood samples at time of clinical evaluation.
- interventionNames
- Other: Cytology Specimen Collection Procedure
Primary outcomes (1)
- measure
- Biologic specimen repository and database
- timeFrame
- Baseline to up to 5 years
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Histologically confirmed Hodgkin's lymphoma (HL) meeting 1 of the following criteria: * Newly diagnosed, untreated HL (for patients under 22 years of age) * Past or present diagnosis of HL and past or present enrollment on a Children's Oncology Group (COG) or legacy HL clinical trial (for patients of any age)
References
Publications (0)
Data not yet available
No reference posted for this study.